Exhibit 10.4
REDACTED VERSION
ALBUMIN SUPPLY AGREEMENT
*** Confidential treatment has been requested as to certain portions of
this agreement. Such omitted confidential information has been designated
by an asterisk and has been filed separately with the Securities and
Exchange Commission pursuant to Rule 24b-2 under the Securities Exchange
Act of 1934, as amended, and the Commission's rules and regulations
promulgated under the Freedom of Information Act, pursuant to a request for
confidential treatment. ***
In Barcelona on this 22 day of June 1999.
BY AND BETWEEN
SERACARE INC., a corporation of USA nationality, with address at 0000 Xxxxxxx
Xxxx Xxxx, Xxxxx 0000, Xxx Xxxxxxx, Xxxxxxxxxx, XXX, represented by Xx. Xxxxx X.
Xxxxx, by virtue of his position as Chairman/CEO (hereinafter referred to as
SERACARE), party to the first part.
INSTITUTO GRIFOLS, S.A., a corporation of Spanish nationality, with address at
Poligono Industrial Levante, Calle Can Xxxxxx, x/x. 00000 Xxxxxx xxx Xxxxxx,
Xxxxxxxxx, Xxxxx, represented by Xx. Xxxxxx Xxxxx Ribes, by virtue of his
position as General Manager, (Hereinafter referred to as GRIFOLS), party of the
second part.
WHEREAS
I. SERACARE is a corporation, which main activity is as a collector of plasma,
distributor of therapeutic and diagnostic plasma derived products, and as a
manufacturer of diagnostic products.
1
II. GRIFOLS is a corporation, which main activity is the manufacturing and
commercialization of Hemoderivatives, including Human Albumin, which are
manufactured in its premises located in Xxxxxx del Xxxxxx.
III. GRIFOLS declares that its Human Albumin complies with the technical
specifications that are detailed in Annex 1 attached hereto, and has all
the necessary and required permits.
IV. That both parties know that GRIFOLS Human Albumin is manufactured for its
direct use and only in accordance with the product indications described in
Annex 2 attached hereto.
V. GRIFOLS is willing to supply and SERACARE to acquire, Human Albumin
(hereinafter referred to as Albumin), due to which, both parties
recognizing in each other enough legal capacity, agree to enter into the
present Albumin Supply Agreement in accordance with the following.
CLAUSES
FIRST - Constitutes the object of the present Agreement, the supply to SERACARE
-------
of Human Albumin manufactured by GRIFOLS, to be sold by SERACARE to third
parties, which may only use said Human Albumin as raw material in its production
of certain products, and never for direct use, in accordance with the provisions
of this Agreement.
2
SECOND - Due to the special technical specifications and quality controls that
--------
the Albumin has to comply with, the parties agree that all the Albumin supplied
by GRIFOLS to SERACARE will have a certified batch release from GRIFOLS.
THIRD - The Albumin supplied by GRIFOLS to SERACARE will be used by any third
-------
party only as raw material, for the purpose of manufacturing products listed in
Annex 3. No other use different from this, including its human use, is covered
by the present Agreement.
The Albumin supplied by GRIFOLS to SERACARE will not be mixed in the
manufacturing process of the products listed in Annex 3 carried out by any third
party with any other product of human origin.
GRIFOLS shall have the right, with prior notification of 24 hours, to require
SERACARE to inspect any third parties' manufacturing facilities and records in
order to verify the correct use of the Albumin supplied/sold by SERACARE to this
third party in accordance with the provisions of the present Agreement.
FOURTH - The quality and technical specifications of the Albumin supplied by
--------
GRIFOLS to SERACARE, as detailed in Annex 1.
The quality and technical specifications, may be changed and/or modified, at
GRIFOLS' requirement, in order to comply with any new legislation in force
and/or new controls or test methods. Any change carried out in accordance will
be duly notified to SERACARE, which shall notify it to all third parties to whom
the Albumin has been supplied/sold.
3
Every shipment of Albumin will be shipped together with all the mandatory and/or
legal documents, as well as any other documents that may be required.
FIFTH - SERACARE will acquire from GRIFOLS the annual quantities established in
-------
Annex 4. Both parties, on a yearly basis, will fix these minimum annual
quantities, as well as the Product price, which will also be included in said
Annex.
In the event that / new test and/or control is required, as stated in Clause
Fifth hereinabove, GRIFOLS and SERACARE shall mutually agree to renegotiate the
prices set forth in this Agreement.
SIXTH - Payment of the Albumin delivered by GRIFOLS to SERACARE would be
-------
payable 30 days after reception by SERACARE in its premises in Oceanside, CA,
USA.
SEVENTH - The Albumin will be shipped and packed in accordance with the
---------
specifications set forth in Annex 5 to the present Agreement.
EIGHTH - For the event that the Albumin supplied by GRIFOLS to SERACARE is
--------
object of a product recall carried out by GRIFOLS, GRIFOLS will be responsible
only for its reposition with new Albumin.
Due to the use that third parties shall give to the Albumin, which will be as
raw material for manufacturing products listed in Annex 3 which is different and
not specified in the Product indications given by GRIFOLS, SERACARE and/or any
third party will be solely responsible for its use in accordance with the
present Agreement, and will hold GRIFOLS harmless of any
4
circumstances derived from the use that SERACARE and/or any third party will
give to the Albumin.
NINTH - SERACARE declares that it has a product liability insurance covering
-------
the products, for an amount of $US 5,000,000 and takes the commitment to have
such insurance coverage while the present Agreement is in force and the products
manufactured using the Albumin have not expired, and will also require that any
third party using the Albumin has a product liability insurance in the same
terms and conditions.
TENTH - All information disclosed by GRIFOLS to SERACARE concerning any aspect
-------
of Albumin, including discussions with Regulatory Authorities, shall be
considered as Confidential Information under this Agreement.
The party receiving the Confidential Information:
1. Will not disclose the Confidential Information to any third party, except as
required by the Regulatory Authorities strictly for the purposes of this
Agreement.
2. Will limit disclosure of the Confidential Information to its employees and
agents who, under obligation of confidentiality, have a need to know of it
for the purposes of this Agreement.
3. Will make no use of the received Confidential Information other than to
fulfill the purposes of this Agreement.
5
4. On termination of this Agreement, will return all such Confidential
Information to the disclosing party, without retaining any copy or extract
thereof.
The following will be exempt from the obligation of this Article:
a) Confidential Information which is now, or which becomes, part of the public
domain without involvement of the receiving party.
b) Confidential Information which the receiving party can demonstrate by
competent proof was known to it before being received from the disclosing
party.
c) Confidential Information which becomes available to the receiving party from
a third party under no obligation of confidentiality to the disclosing
party.
The obligations of this article shall continue after termination of this
Agreement.
ELEVENTH - SERACARE shall, prior to any sale of Albumin to any third party,
----------
inform GRIFOLS of the identity of said third party, as well as sign an agreement
with this third party that shall cover the following:
- Use that this third party may do of the Albumin, which is as detailed in the
manufacturing of products listed in Annex 3.
- Manufacturing information by which this third party has to inform SERACARE
and GRIFOLS of the lot numbers of the products manufactured using GRIFOLS
Albumin.
- Product liability insurance as foreseen in Clause Ninth of the present
Agreement.
6
- Signature of a Confidential Disclosure Agreement between said third party and
GRIFOLS, which will be that attached as enclosure 6 hereto.
- Responsibility Clause identical to that foreseen in Clause Eighth of the
present Agreement.
- Force Majeure Clause identical to that foreseen in Clause Thirteenth of the
present Agreement.
- Rescission/termination clause, which covers any breach of the clauses of the
Agreement by the third party, especially if the Albumin is not used as raw
material in the manufacturing of products listed in Annex 3, and a different
use is given to it.
- Clause including that SERACARE shall have the right, with a prior
notification of 24 hours, to inspect the third parties' manufacturing
facilities and records, in order to verify the correct use of the Albumin
supplied by GRIFOLS in accordance with the provisions of the present
Agreement.
TWELFTH - The duration of the present Agreement will be until 31st December
---------
1999, and will start on the date of its signature. The Agreement will be
automatically renewed for one-year periods if neither party denounces it three
months before its expiry.
THIRTEENTH - Neither party shall be liable for non-performance of this
------------
Agreement due to Force Majeure. Force Majeure will have the meaning stated
below under (a):
7
a) Strikes, lockouts, other industrial disturbances, rebellions, mutinies,
epidemics, landslides, lightning, earthquakes, fires, storms, floods,
sinking, drought, civil disturbances, explosions, act or decisions of duly
constituted municipal, state or National Governmental Authorities or of
Courts of Law, impossibility to obtain supplies, fuel or other required
materials, or any other causes similar or completely different, all beyond
the control of the Party pleading Force Majeure preventing the Party from
performing its rights and obligations and not to be overcome by due
diligence of such Party.
b) The Parties agree that if either of them find themselves wholly or partly
unable to fulfill their respective obligations in this Agreement by reason
of Force Majeure, the Party pleading Force Majeure will as soon as possible
notify the other Party of its inability to perform giving detailed
explanation of the occurrence which excuses performance. If said notice is
given, the performance of the notifying party shall be abated for so long as
performance may be prevented by Force Majeure. A Party unable to perform due
to Force Majeure shall resume fulfilling its obligations, including making
the due payments, after the Force Majeure has ceased. All terms will be
extended by the time period the Force Majeure has lasted.
FOURTEENTH - The present Agreement will be terminated and will become null due
------------
to any of the following reasons:
a) Mutual agreement.
b) Those fixed by law.
8
c) With thirty (30) days notice if the other party shall default in the
performance or observation of any material provisions of this Agreement and
shall fail to cure such default within sixty (60) days after notice from
such party, and the non-defaulting party shall reserve a right to seek a
remedy available under the applicable laws.
d) If any party falls into suspension of payments or becomes bankrupt.
e) Not meeting payments due.
f) Any substantial change in the ownership in any of the parties which may give
rise to a change in the political control of the Company, or the
participation through the acquisition of shares by a direct competitor of
any of the parties.
FIFTEENTH -
-----------
a) Any notice required or provided for by the terms of this Agreement shall be
made in writing and shall be sent by registered mail postage prepaid or by
telex or by facsimile properly addressed in accordance with the addresses
first above given or to such other addresses as the parties may at a later
date advise. The effective date of this notice shall be six (6) days after
the date of sending such notice.
b) This Agreement constitute the entire agreement between the parties
concerning the subject matter hereof. None of the terms of this Agreement
shall be amended or modified except in writing signed by the parties hereto.
The headings used in this Agreement are only meant for easy reading of the
Agreement.
9
c) Provisions of this Agreement are separate and divisible and the invalidity
or unenforceability of any part shall not affect the validity or
enforceability of any remaining part or parts, all of which shall remain in
full force and effect. However, the parties agree to substitute any invalid
or unenforceable provision by valid and enforceable arrangement which
achieves to the greatest extent possible the financial balance and mutual
understanding already established between the parties.
SIXTEENTH - Any dispute, controversy or difference that may arise from the
-----------
interpretation or in connection with the present Agreement or as the compliance
of any other obligations contained herein, shall be submitted to arbitration
held in Barcelona (Spain), in the "Tribunal Arbitral de Barcelona" according to
its rules. The award rendered in any such arbitration shall be final and
binding upon the parties hereto.
SEVENTEENTH - The parties agree that the present document is a commercial
-------------
agreement and is ruled by the Clauses contained herein, and shall be governed by
the laws of Spain, by Spanish commercial usage or, in its case, by the Spanish
Civil Code.
In witness whereof, the present Agreement is signed in duplicate in the place
and date first written above.
INSTITUTO GRIFOLS, S.A. SERACARE INC.
/s/ Xxxxxx Xxxxx Ribes /s/ Xxxxx X. Xxxxx
10
LIST OF OMITTED ANNEXES
The following Annexes to the Albumin Supply Agreement have been omitted from
this Exhibit and shall be furnished to the Commission upon request:
Annex Document
----- --------
2 USA Package Insert
3 Human Albumin as Raw Material
5 Shipment Information
6 Confidential Disclosure Agreement
ANNEX 1
***
_________________
*** Confidential information omitted and filed separately with the Securities
and Exchange Commission.
ANNEX 4
HUMAN ALBUMIN GRIFOLS
QUANTITIES AND PRICE
- The quantities established for the year 1999 will be in the range of Ten
Thousand (10,000)* - Twelve Thousand (12,000) vials per month.
- Product price:
- Human Albumin Grifols at *** per gram FOB Barcelona.
_________________
*** Confidential information omitted and filed separately with the Securities
and Exchange Commission.
